Form 4: LifeStance Health Director Teresa DeLuca Boosts Stake with RSU Grant
Insider Transaction Report
LifeStance Health Group, Inc. Director Teresa DeLuca has increased her beneficial ownership by acquiring 35,714 shares of common stock through a restricted stock unit grant.
Summary
- Teresa DeLuca, a Director of LifeStance Health Group, Inc. (LFST), acquired 35,714 shares of common stock.
- The acquisition occurred on June 11, 2025, and was made at a price of $0 per share, indicating a grant of restricted stock units (RSUs).
- Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- Following this transaction, Ms. DeLuca's total beneficial ownership in LifeStance Health Group, Inc. stands at 107,288 shares.
- The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged acquisition.
Sentiment
Score: 7
Explanation: The acquisition of shares by a director, particularly through an RSU grant, is generally viewed positively as it aligns management's interests with shareholders and is a standard form of compensation.
Positives
- Director Teresa DeLuca increased her beneficial ownership in LifeStance Health Group, Inc. by 35,714 shares, aligning her interests further with shareholders.
- The acquisition was through a grant of restricted stock units, a common form of equity compensation that incentivizes long-term performance and retention.
- The transaction was conducted under a Rule 10b5-1(c) plan, suggesting a pre-scheduled and transparent acquisition.
Future Outlook
NA
Industry Context
NA
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Insider Trading Plan | The transaction was made pursuant to a Rule 10b5-1(c) contract, instruction or written plan, indicating a pre-arranged and compliant trading strategy. | 06/11/2025 | Enhances transparency and reduces concerns about opportunistic insider trading. |
Stakeholder Impact
- Shareholders: The increase in director ownership through equity compensation can be seen positively as it aligns the director's financial interests with those of the shareholders, potentially signaling confidence in the company's long-term performance.
Key Dates
| Date | Description |
|---|---|
| 06/11/2025 | Date of transaction (acquisition of shares) |
| 06/13/2025 | Date the Form 4 was signed and filed |
Keywords
LifeStance Health Group, LFST, Teresa DeLuca, Director, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU, Equity Compensation, Share Acquisition, Beneficial Ownership, Corporate Governance, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.